Form 10-Q Voyager Therapeutics, For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Voyager Therapeutics (VYGR) PT Lowered to $8 at Wedbush
May 14, 2024 6:47 AM EDTWedbush analyst Laura Chico lowered the price target on Voyager Therapeutics (NASDAQ: VYGR) to $8.00 (from $10.00) while maintaining a Neutral rating.
The analyst comments "Remain Neutral rated on VYGR, new $8 target. On the heels of the AGCST meeting, the 1Q24 VYGR update... More
